BenevolentAI

BenevolentAI is a clinical-stage AI drug discovery company that uses its proprietary Benevolent Platform to analyze vast biomedical datasets and identify novel targets and drug candidates for complex diseases. The platform integrates knowledge graphs, natural language processing, and machine learning to connect disparate scientific data sources and uncover hidden relationships between genes, diseases, and compounds. BenevolentAI has advanced multiple programs into clinical development, includ...

Threads